{"transactions":[{"id":763757,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock","published_at":"2026-05-26T22:00:27.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":998,"price":11.21,"value":11187.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."}],"balance_after":27399,"source":{"system":"sec-edgar","filing":"0002048466-26-000003","document":"form4-05262026_060522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000003/form4-05262026_060522.xml","form_type":"4"}},{"id":763756,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:27.000Z","date":"2026-05-21","kind":"grant","planned":true,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":28397,"source":{"system":"sec-edgar","filing":"0002048466-26-000003","document":"form4-05262026_060522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000003/form4-05262026_060522.xml","form_type":"4"}},{"id":763755,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:27.000Z","date":"2026-05-21","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":9.95,"value":9950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."}],"balance_after":11432,"source":{"system":"sec-edgar","filing":"0002048466-26-000003","document":"form4-05262026_060522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000003/form4-05262026_060522.xml","form_type":"4"}},{"id":939210,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:06.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":12432,"source":{"system":"sec-edgar","filing":"0002048466-26-000002","document":"form4-01142026_080103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846626000002/form4-01142026_080103.xml","form_type":"4"}},{"id":983555,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T21:20:08.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":29.91,"value":14955.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $29.91 and the range of prices were between $29.80 and $30.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":8435,"source":{"system":"sec-edgar","filing":"0002048466-25-000005","document":"form4-12022025_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000005/form4-12022025_041204.xml","form_type":"4"}},{"id":983554,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-02T21:20:08.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":906,"price":29.3463,"value":26587.7478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":8935,"source":{"system":"sec-edgar","filing":"0002048466-25-000005","document":"form4-12022025_041204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000005/form4-12022025_041204.xml","form_type":"4"}},{"id":1006828,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T02:45:07.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":38,"price":27.7,"value":1052.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."}],"balance_after":9841,"source":{"system":"sec-edgar","filing":"0002048466-25-000003","document":"form4-11052025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000003/form4-11052025_091104.xml","form_type":"4"}},{"id":1006827,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T02:45:07.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":1368,"price":26.8474,"value":36727.2432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $26.8474 and the range of prices were between $26.27 and $27.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":9879,"source":{"system":"sec-edgar","filing":"0002048466-25-000003","document":"form4-11052025_091104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000204846625000003/form4-11052025_091104.xml","form_type":"4"}},{"id":1199822,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T00:00:11.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":11247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":11247,"source":{"system":"sec-edgar","filing":"0001415889-25-008534","document":"form4-03182025_080304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925008534/form4-03182025_080304.xml","form_type":"4"}},{"id":1287409,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44221,"kind":"person","name":"Lezack Adam","position":1,"cik":"0002048466","reported_name":"Lezack Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-04T01:30:17.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":9137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in 36 equal monthly installments measured from December 12, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock."}],"balance_after":9137,"derivative":{"exercise_price":5.1,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":9137},"source":{"system":"sec-edgar","filing":"0001415889-25-002820","document":"form4-02032025_080213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925002820/form4-02032025_080213.xml","form_type":"4"}}]}